非心脏去极化阻滞药物与院外心脏骤停首次注册心律及生存的关联
研究基于丹麦全国心脏骤停注册(2001-2020年),纳入54,370例医疗原因院外心脏骤停患者,其中6,284例(11.6%)在骤停前90天内使用过非心脏去极化阻滞药物。在多因素校正后,用药者与非用药者相比,非可除颤心律的比值升高(OR 1.62,95%CI 1.48-1.79),且该关联在男女、各年龄组、无精神或非心血管疾病史者以及不同年份分层中一致。用药者30天生存的比值低于非用药者(OR 0.81,95%CI 0.69-0.95)。作者结论认为,非心脏去极化阻滞药物的使用与院外心脏骤停非可除颤心律及较低30天生存相关。
要点
- 院外心脏骤停前90天内使用非心脏去极化阻滞药物者,非可除颤心律的比值升高(OR 1.62,95%CI 1.48-1.79)。
- 该关联在男性(OR 1.72,95%CI 1.53-1.95)和女性(OR 1.46,95%CI 1.26-1.70)中一致。
- 年龄<60岁者OR 1.91(95%CI 1.54-2.39),>60岁者OR 1.57(95%CI 1.41-1.74),各年龄组均见关联。
- 用药者院外心脏骤停后30天生存的比值低于非用药者(OR 0.81,95%CI 0.69-0.95)。
- 研究为观察性注册分析,非心脏去极化阻滞药物使用定义为骤停前90天内处方记录。
适用人群与场景
- 丹麦全国心脏骤停注册(2001-2020年)中医疗原因的院外心脏骤停患者,共54,370例(男性63.1%,中位年龄74岁)。
- 非心脏去极化阻滞药物使用定义为院外心脏骤停前90天内有处方记录,共6,284例(11.6%)。
研究设计与关键结果
- 研究类型为基于全国注册的观察性研究,纳入54,370例医疗原因院外心脏骤停患者,比较骤停前90天内使用与非使用非心脏去极化阻滞药物者。
- 主要终点:校正混杂因素后,用药者非可除颤心律的比值高于非用药者(OR 1.62,95%CI 1.48-1.79)。
- 分层分析:男性OR 1.72(95%CI 1.53-1.95),女性OR 1.46(95%CI 1.26-1.70);年龄<60岁OR 1.91(95%CI 1.54-2.39),>60岁OR 1.57(95%CI 1.41-1.74)。
- 在无既往精神疾病或非心血管疾病者中,以及按院外心脏骤停发生年份分层时,非可除颤心律比值升高的一致性均保持。
- 用药者30天生存的比值低于非用药者(OR 0.81,95%CI 0.69-0.95)。
证据类型、等级与局限
- 证据类型:基于丹麦全国心脏骤停注册(2001-2020年)的观察性研究,采用多因素logistic回归校正相关混杂因素。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于院外心脏骤停患者,若骤停前90天内有非心脏去极化阻滞药物处方记录,急救团队应意识到其首次注册心律为非可除颤心律的比值更高(OR 1.62),30天生存的比值更低(OR 0.81)。
- 该关联为观察性研究结果,原文未据此给出改变用药或复苏流程的推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Out-of-hospital cardiac arrest (OHCA) is one of the leading causes of mortality worldwide. Survival following OHCA largely depends on whether the initial heart rhythm is shockable or non-shockable. Previous research has suggested that drugs with an off-target effect of blocking cardiac depolarization (non-cardiac depolarization-blocking (DB) drugs) may be associated with a higher likelihood of having a non-shockable rhythm. In this study, we examined whether the use of non-cardiac DB-drugs affects the initial rhythm and survival in OHCA.
METHODS: We identified all patients with OHCA of medical causes from the nationwide Danish Cardiac Arrest Registry (2001-2020). Non-cardiac DB-drug use was defined by prescriptions within 90 days prior to OHCA. Multiple logistic regression models with adjustments for relevant confounders were employed to estimate the odds ratio (OR) for the association between non-cardiac DB-drugs and initial heart rhythm and 30-day survival following OHCA. Additionally, stratified analyses were performed based on sex, age, cardiovascular and psychiatric comorbidities, and the year of OHCA occurrence.
RESULTS: We included 54,370 OHCA patients (63.1 % male, median age 74 years). Non-cardiac DB-drugs was used by 6284 (11.6 %) OHCA patients and was associated with increased odds of non-shockable rhythm compared with non-users after adjustment for relevant confounders (OR 1.62, 95 % CI: 1.48-1.79). This increased odds of non-shockable rhythm was consistent in men and women (ORmen: 1.72, 95 % CI: 1.53-1.95, ORwomen 1.46, 95 % CI: 1.26-1.70), in all age categories (OR<60 years 1.91, 95 % CI: 1.54-2.39, OR>60 years 1.57, 95 % CI: 1.41-1.74), in the absence of pre-existing psychiatric or non-cardiovascular disease, or when stratified by the year of OHCA occurrence. Finally, we found that users of non-cardiac DB-drugs had lower 30-day survival chances following OHCA when compared to non-users (OR 0.81, 95 % CI: 0.69-0.95).
CONCLUSION: Use of non-cardiac DB-drugs was associated with increased odds of non-shockable rhythm in OHCA and with lower 30-day survival following OHCA.
参考来源
- Hindborg M, Coronel R, Arulmurugananthavadivel A, et al. Association of non-cardiac depolarization-blocking drugs with first-registered heart rhythm and survival in out-of-hospital cardiac arrest. Resuscitation. 2025. PMID: 41270993. doi:10.1016/j.resuscitation.2025.110903
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。